History
A descendant of a Chinese stem cell research company with 19 years of research and clinical applications, ICT U.S. strives to be one of the top stem cell research and application facilities in North America.
Specialties
ICT U.S.-Inheritor Cell Technology (USA) Inc. is a biopharmaceutical company specializing in biobank, research and clinical applications of stem cells. We are devoted to providing services in stem cell manufacturing, clinical application, therapy and biologics; with a commitment to services in disease research, genetic tests, assisted reproduction, organ regeneration, genetic science, etc.